Home › Alcohol Use Disorder (AUD) › NCT05163301
Alcohol Research in HIV: Relapse Prevention
Recruiting
Alcohol Research Consortium in HIV: Relapse Prevention Arm
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Confirmed diagnosis of HIV * Aged 18 years or older * Must be enrolled in clinical care at Johns Hopkins HIV Clinic. In addition, meet the following alcohol use criteria: 1. lifetime alcohol use disorder 2. patient reported outcomes (PRO) assessment collected by the Center for AIDS Research (CFAR) Network of Clinical Systems as part of usual clinical care that show in the last 3 years: periods of no or lower risk drinking (e.g. women/men who are drinking \<11/22 drinks per week) and periods of lapse to higher levels of drinking (=\>11/22 drinks per week for women/men) 3. current PRO showing alcohol abstinence or alcohol use at \<11/22 drinks per week for women/men. Exclusion Criteria: * Acutely suicidal, homicidal, psychotic or otherwise unable to provide informed consent * Non-English speaking because interventions are currently available in English only
About the study
3-arm type 1 pilot implementation-efficacy trial for people with alcohol use disorders to examine the preliminary effectiveness and feasibility of an adapted 2-session, computerized and person delivered relapse prevention intervention.
What is being tested
- Relapse Prevention Intervention (behavioral)
Sponsor: Johns Hopkins University · Participants: 150 · Started: Mar 27, 2023
Contact the study team
- Heidi Hutton, PhD · Phone: 14104586715
Official record on ClinicalTrials.gov — NCT05163301
Locations in the U.S.
| Maryland | Johns Hopkins School of Medicine, Baltimore |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.